Skip to main content

Venker Eric's Form 4 filing

Roivant Sciences Ltd. (ROIV) · filed Jun 4, 2025

Accession no.
0001140361-25-021455
Filed
Jun 4, 2025
Trade date
Jun 2-3, 2025
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $11.2M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Venker EricCIK 0001801917Officer (President & COO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 2, 2025Common SharesMOption exerciseAcquired+600,000$3.85+$2,310,0001,677,197Direct
Jun 2, 2025Common SharesSSaleDisposed−433,722$11.07F1−$4,801,302.541,243,475Direct
Jun 3, 2025Common SharesMOption exerciseAcquired+785,026$3.85+$3,022,350.12,028,501Direct
Jun 3, 2025Common SharesSSaleDisposed−566,278$11.22F1−$6,353,639.161,462,223Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 2, 2025Common StockMOption exerciseDisposed−600,000$0.00$09,123,923Direct
Jun 3, 2025Common StockMOption exerciseDisposed−785,026$0.00$08,338,897Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.

Referenced by the price of 2 transactions in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)